Peripheral Artery Disease (PAD) Clinical Trial
Official title:
Prestige Pilot - Phoenix Atherectomy and Stellarex DCB Clinical Investigation in Infrapopliteal Interventions
This pilot study is to investigate if a lesion preparation strategy with Phoenix atherectomy before DCB (drug coated balloon) usage in patients with PAD (peripheral artery disease) Rutherford Stage 4-5 and mild/moderate/severe calcium can improve outcomes including patency and limb salvage and evaluate safety and performance of the combination therapy
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02227368 -
Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
|
Phase 2 | |
| Recruiting |
NCT06052319 -
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
|
||
| Recruiting |
NCT05941533 -
Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease
|
||
| Active, not recruiting |
NCT02924857 -
The Chocolate Touch Study
|
N/A | |
| Not yet recruiting |
NCT05665816 -
Results of the Treatment of Medium and Long de Novo and Restenotic Lesions in the Superficial Femoral Artery and/or Popliteal Artery With Primary or Salvage Pulsar® -18 t3 Stent
|
||
| Active, not recruiting |
NCT04821388 -
Α Pre CE-Marking Study Using the Rontis Drug Coated Balloon for Treatment of Lesions in Femoropopliteal Arteries
|
N/A | |
| Recruiting |
NCT03304821 -
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
|
Phase 2 | |
| Completed |
NCT02220686 -
Vascular Physician Offer and Report (VAPOR) Trial
|
N/A |